In colorectal cancer cells, CCL19 activates CCR7, thereby inducing miR-206 upregulation, which suppresses angiogenesis to inhibit the ERK/MAPK-HIF-1-VEGF pathway [62]. Here, CCL19 is linked to colorectal cancer.